Placebo Current Events | Placebo News | 9
|
| Page
9 of
26 |
519 Results |
|
|
|
Sort By:
Page Views | Date |
Golimumab significantly reduced signs and symptoms of ankylosing spondylitis
More than half of patients receiving monthly subcutaneous (SC) injections of golimumab (CNTO 148) 50 mg and 100 mg experienced significant and sustained improvements in the signs and symptoms of active ankylosing spondylitis, according to Phase 3 study results presented at the American College of Rheumatology (ACR) annual meeting. view more (2007-11-08)
South African Geraniums Effective in Treatment of Adults with Acute Bronchitis
A recent clinical trial in Europe showed that EPs® 7630, a remedy made from the roots of Pelargonium sidoides-a species of geranium unique to South Africa, is an effective alternative treatment of acute bronchitis. view more (2005-12-14)
Complementary and alternative therapies show little benefit in treating menopause symptoms
Insufficient evidence exists to support the use of complementary and alternative therapies to relieve menopause-related symptoms. view more (2006-07-25)
ESC Congress 2004: Trial shows benefits of new anti-arrhythmetic agent, dronedarone, in the management of cardiac arrhythmia
On behalf of the Steering Committee of the EURopean trial In atrial fibrillation or flutter patients receiving Dronedarone for the maIntenance of Sinus rhythm view more (2004-08-29)
Phase 3 data show golimumab improved psoriatic arthritis symptoms
Patients with active psoriatic arthritis receiving monthly subcutaneous (SC) injections of golimumab (CNTO 148) experienced significant and sustained improvements in the joint and skin manifestations of the disease. view more (2007-11-08)
Glucosamine supplements reduce knee pain
Glucosamine supplements reduce knee pain in people with cartilage damage and possibly the degenerative joint disease osteoarthritis, concludes research in the British Journal of Sports Medicine. view more (2003-01-24)
Depression may increase Alzheimer's risk in people with memory problems
People with memory problems who are depressed are more likely to develop Alzheimer's disease than those who aren't depressed, according to a new UCLA study. view more (2009-06-16)
Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
Vitamins C and E and beta carotene, either individually or in combination, do not appear to reduce the risk of cardiovascular events or death among women at high risk for heart disease. view more (2007-08-14)
New study: Pine bark extract reduces ADHD symptoms in children
Attention Deficit Hyperactivity Disorder (ADHD) is a prevailing issue in the United States, with millions of children getting diagnosed every year. A new study reveals that Pycnogenol, (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, reduces ADHD in children. view more (2007-09-13)
Invitation to the Press - Magnesium Sulphate Halves Risk Of Eclampsia For Pregnant Women With Pre-eclampsia (pp 1872, 1877)
A landmark international study in this week's issue of THE LANCET highlights how magnesium sulphate can substantially reduce the chance of pregnant women who have pre-eclampsia developing the potentially fatal condition of eclampsia. The striking findings and low cost of magnesium sulphate ($5 per patient) could result in a significant change in... view more... (2002-05-29)
Tamoxifen chemoprevention tied to early detection of breast cancer
The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute. view more (2008-10-08)
Consumption of fish oil does not appear to protect against abnormal heart rhythms
Patients with an implantable cardioverter defibrillator did not have a significantly lower risk of serious abnormal heart rhythms or death by consuming fish oil supplements, which had been thought to have a protective effect. view more (2006-06-14)
Omega-3 supplements affect Alzheimer's symptoms
Omega-3 supplements can, in certain cases, help combat the depression and agitation symptoms associated with Alzheimer's disease, according to a clinical study conducted at the Swedish medical university Karolinska Institutet. view more (2007-06-21)
Taking folic acid does not reduce risk of precancerous colon tumors
Taking folic acid supplements does not reduce the risk of developing precancerous tumors in the colon and may even increase the risk, a new study has found. view more (2007-06-11)
Merck's odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
Two-year data from a Phase IIB study of odanacatib (formerly MK-0822), an investigational, selective cathepsin-K inhibitor in development for the treatment of osteoporosis by Merck & Co., Inc., demonstrated dose- dependent increases in bone mineral density (BMD) at the total hip, lumbar spine and femoral neck fracture sites and decreased... view more... (2008-09-17)
Ibuprofen or acetaminophen in long-term resistance training increases muscle mass/strength
Taking daily recommended dosages of ibuprofen and acetaminophen caused a substantially greater increase over placebo in the amount of quadriceps muscle mass and muscle strength gained during three months of regular weight lifting, in a study by physiologists at the Human Performance Laboratory, Ball State University. view more (2008-04-07)
Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors
A winter free from colds and flu? Not yet. But a new study offers new evidence that Canada's top cold and flu-fighting product provides significant help. view more (2008-09-16)
Prenatal multivitamins for undernourished women may reduce risk of low birth weight
Undernourished women who take a vitamin and mineral supplement while pregnant may be less likely than women taking only iron and folic acid supplements to have babies weighing less than 2,500 grams, and their newborns may be less likely to have morbidity in the first seven days of life. view more (2007-01-02)
BUPROPION SUSTAINS SMOKING CESSATION FOR SMOKERS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE (pp 1550, 1571)
The antidepressant drug bupropion (Zyban) could substantially curb heavy smoking among smokers with chronic obstructive pulmonary disease (COPD), conclude authors of a study in this week's issue of THE LANCET. COPD is preventable and is one of the leading causes of illness and death worldwide; it is associated with smoking in 80% of cases.... view more... (2001-05-16)
Study produces conflicting findings on the use of anti-anemia drug in cancer patients
Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo. view more (2007-04-17)
|
|
| Page
9 of
26 |
519 Results |
|
|
|
Sort By:
Page Views | Date |
|
